EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparing anti-platelet and anti-thrombin therapies in the ischaemia–reperfusion injured coronary microcirculation of healthy and diabetic mice

Joanne L Mitchell, Juma El-Awaisi, Dean Kavanagh, Bernhard Nieswandt, Robert F Storey, Neena Kalia iD

Basic Research in Cardiology · 02.04.2026 · 121 (3) · 351-370

DOI: 10.1007/s00395-026-01168-7 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Basic Research in Cardiology, online erschienen am 02.04.2026. Verfasst von Joanne L Mitchell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Microcirculation Research Group, Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Bir…. Hauptthemen laut MEDLINE: Microcirculation, Myocardial Reperfusion Injury, Platelet Aggregation Inhibitors, Antithrombins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Biochemical Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with type 2 diabetes mellitus (T2DM) face increased risk of heart failure after myocardial infarction (MI), despite successful PCI and dual anti-platelet therapy (DAPT), due to coronary microvascular obstruction. This study examined whether DAPTs provide vasculoprotective benefits in injured coronary microvessels, including in the setting of chronic hyperglycaemia. Mice were fed a normal (ND) or high-fat diet (HFD) for 16 weeks and treated with vehicle, aspirin plus ticagrelor, clopidogrel, prasugrel or cangrelor, anti-GPIbα antibody, or dabigatran. Intravital imaging assessed platelet, neutrophil, and fibrin presence in the beating heart subjected to ischaemia–reperfusion injury (IRI). Laser speckle contrast imaging evaluated overall ventricular perfusion, and infarct size was determined histologically. IRI increased platelet and neutrophil accumulation in coronary capillaries and reduced perfusion. DAPTs, particularly using prasugrel, and anti-GPIbα reduced platelet numbers but increased neutrophil infiltration. Despite limited perfusion improvement, infarct size decreased. Fibrin deposition was also extensive and contributed to platelet recruitment, as shown using dabigatran. HFD-fed mice demonstrated markedly elevated thromboinflammatory cell accumulation. DAPT with prasugrel reduced platelet and neutrophil presence, but left a significant residual presence of both. Despite perfusion improvements, infarcts remained larger. Our data do not support a simple linear relationship between reduced platelet microthrombi, improved perfusion, and infarct limitation. Whilst early platelet inhibition confers cardioprotection independently of flow recovery in healthy mice, metabolic compromise uncouples microvascular flow from myocardial tissue survival. This may explain the diminished cardioprotective efficacy of DAPTs in patients with T2DM and supports exploring combination vasculoprotective therapies targeting multiple microvascular perturbations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrocirculationMyocardial Reperfusion InjuryPlatelet Aggregation InhibitorsAntithrombinsCoronary CirculationDiabetes Mellitus, Type 2Diabetes Mellitus, ExperimentalCoronary VesselsMyocardial InfarctionAnimalsMaleMice, Inbred C57BLDisease Models, AnimalMiceIntravital MicroscopyBlood Platelets

Stichwörter der Autor:innen

Coronary microcirculationHyperglycaemiaIntravital microscopyIschaemia–reperfusion injuryNeutrophilsP2Y12 receptor inhibitorsPlatelets

Substanzen

Platelet Aggregation InhibitorsAntithrombins

Autor:innen und Institutionen

  • Microcirculation Research Group, Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, UK.
  • Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.
  • Division of Clinical Medicine, University of Sheffield, Sheffield, UK.
  • NIHR Sheffield Biomedical Research Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Microcirculation Research Group, Department of Cardiovascular Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham, B15 2TT, UK. n.kalia@bham.ac.uk.

ORCID-Profile: Neena Kalia

Förderung

  • British Heart Foundation
  • Biochemical Society

Zitieren

APA

Mitchell, J. L., El-Awaisi, J., Kavanagh, D., Nieswandt, B., Storey, R. F., & Kalia, N. (2026). Comparing anti-platelet and anti-thrombin therapies in the ischaemia–reperfusion injured coronary microcirculation of healthy and diabetic mice. Basic Research in Cardiology, 121(3), 351-370. https://doi.org/10.1007/s00395-026-01168-7

Vancouver

Mitchell JL, El-Awaisi J, Kavanagh D, Nieswandt B, Storey RF, Kalia N. Comparing anti-platelet and anti-thrombin therapies in the ischaemia–reperfusion injured coronary microcirculation of healthy and diabetic mice. Basic Research in Cardiology. 2026;121(3):351-370. doi:10.1007/s00395-026-01168-7

BibTeX
@article{Mitchell2026,
  author = {Mitchell, Joanne L and El-Awaisi, Juma and Kavanagh, Dean and Nieswandt, Bernhard and Storey, Robert F and Kalia, Neena},
  title = {Comparing anti-platelet and anti-thrombin therapies in the ischaemia–reperfusion injured coronary microcirculation of healthy and diabetic mice},
  journal = {Basic Research in Cardiology},
  year = {2026},
  volume = {121},
  number = {3},
  pages = {351--370},
  doi = {10.1007/s00395-026-01168-7}
}
Kostenlos starten →